Waters Corporation $WAT Position Raised by Calamos Advisors LLC

Calamos Advisors LLC increased its holdings in shares of Waters Corporation (NYSE:WAT) by 548.9% in the 3rd quarter, Holdings Channel.com reports. The firm owned 51,353 shares of the medical instruments supplier’s stock after acquiring an additional 43,439 shares during the quarter. Calamos Advisors LLC’s holdings in Waters were worth $22,564,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Pilgrim Global Advisors LLC purchased a new position in Waters in the second quarter valued at approximately $466,131,171,000. BlackRock Inc. acquired a new stake in Waters during the second quarter worth approximately $3,182,191,000. State Street Corp raised its holdings in Waters by 0.5% during the second quarter. State Street Corp now owns 4,382,008 shares of the medical instruments supplier’s stock worth $1,643,428,000 after purchasing an additional 19,998 shares in the last quarter. Jupiter Topco LLC purchased a new stake in shares of Waters during the 2nd quarter worth approximately $623,921,000. Finally, Wellington Management Group LLP lifted its position in shares of Waters by 69.2% during the 2nd quarter. Wellington Management Group LLP now owns 1,373,150 shares of the medical instruments supplier’s stock worth $514,986,000 after buying an additional 561,824 shares during the last quarter. 94.01% of the stock is owned by institutional investors and hedge funds.

Trending Headlines about Waters

Here are the key news stories impacting Waters this week:

• Positive Sentiment: Waters reported $1.77 billion in third-quarter 2026 revenue and raised its full-year guidance, signaling improved expectations for the business. Waters Corporation Reports $1.77 Billion in Third Quarter 2026 Revenue and Raises Full-Year Guidance
• Positive Sentiment: The company agreed to acquire MOBILion Systems, expanding its mass spectrometry and AI-powered proteomics capabilities. The strategic fit could broaden Waters’ technology offering, though the reported item does not quantify the deal’s financial impact. Waters Corporation Acquires MOBILion Systems
• Positive Sentiment: JPMorgan, Barclays, KeyCorp, TD Cowen, Citigroup, and RBC issued reports indicating higher price targets or strong potential appreciation, reinforcing a favorable analyst outlook. JPMorgan price target Barclays outlook KeyCorp outlook TD Cowen price target Citigroup price target RBC outlook

Waters Price Performance

Shares of NYSE:WAT opened at $457.92 on Friday. The company has a 50-day simple moving average of $434.72 and a 200-day simple moving average of $372.24. Waters Corporation has a one year low of $282.77 and a one year high of $482.28. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.29 and a current ratio of 0.66. The stock has a market capitalization of $44.99 billion, a price-to-earnings ratio of 196.53, a PEG ratio of 2.60 and a beta of 1.16.

Waters (NYSE:WAT) last announced its earnings results on Tuesday, November 3rd. The medical instruments supplier reported $4.10 earnings per share for the quarter, topping the consensus estimate of $4.00 by $0.10. Waters had a net margin of 1.75% and a return on equity of 9.91%. The business had revenue of $1.77 billion during the quarter, compared to the consensus estimate of $1.75 billion. During the same quarter in the prior year, the firm earned $3.40 earnings per share. The business’s quarterly revenue was up 120.9% compared to the same quarter last year. On average, analysts predict that Waters Corporation will post 14.65 EPS for the current year.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on WAT. Deutsche Bank Aktiengesellschaft upped their target price on shares of Waters from $400.00 to $440.00 in a report on Thursday, October 15th. Morgan Stanley set a $430.00 price target on shares of Waters in a research note on Wednesday, August 5th. Royal Bank Of Canada boosted their price target on shares of Waters from $475.00 to $525.00 and gave the company an “outperform” rating in a research report on Wednesday. Robert W. Baird boosted their price target on shares of Waters from $456.00 to $495.00 and gave the company an “outperform” rating in a research report on Thursday, October 8th. Finally, Wall Street Zen upgraded shares of Waters from a “hold” rating to a “buy” rating in a research note on Monday, October 26th. One investment analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $475.48.

Waters Company Profile

Waters Corporation develops and supplies analytical instruments, software, and consumables used to identify, measure, and characterize chemical and biological materials. Its products include liquid chromatography and mass spectrometry systems, which help customers analyze complex samples.

The company serves pharmaceutical and biotechnology businesses, academic and government laboratories, and customers in fields such as food, environmental testing, and materials science. Waters operates internationally, with customers and operations across multiple regions.

Founded in 1958 by James L.